Bernstein Maintains Market Perform on Amgen, Raises Price Target to $345

Benzinga Newsdesk www.benzinga.com Positive 83.4%

Neg 0% Neu 0% Pos 83.4%

Bernstein analyst Courtney Breen maintains Amgen (NASDAQ:AMGN) with a Market Perform and raises the price target from $335 to $345.